Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 13, 2021 - Issue
Submit an article Journal homepage
144
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Maria Mareque1 Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, SpainCorrespondence[email protected]
View further author information
,
Pau Montesinos2 Hospital Universitario La Fe, Valencia, SpainView further author information
,
Patricia Font3 Hospital General Universitario Gregorio Marañón, Madrid, SpainView further author information
,
José María Guinea4 Organización Sanitaria Integrada Araba, País Vasco, SpainView further author information
,
Adolfo de la Fuente5 Hospital MD Anderson, Madrid, SpainView further author information
,
Javier Soto6 Pfizer, Madrid, SpainORCID Iconhttps://orcid.org/0000-0001-7726-9030View further author information
ORCID Icon,
Itziar Oyagüez1 Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, SpainORCID Iconhttps://orcid.org/0000-0002-3047-6152View further author information
ORCID Icon,
James Brockbank7 RTI Health Solutions, Manchester, UKORCID Iconhttps://orcid.org/0000-0002-5349-6017View further author information
ORCID Icon,
Tamara Iglesias6 Pfizer, Madrid, SpainView further author information
,
Julia Llinares6 Pfizer, Madrid, SpainView further author information
&
Jorge Sierra8 Hospital Universitario de La Santa Creu i Sant Pau, Barcelona, SpainView further author information
 show all
Pages 263-277 | Published online: 22 Apr 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lan Gao, Dieu Nguyen & Peter Lee. (2022) A systematic review of economic evaluations for the pharmaceutical treatment of chronic lymphocytic leukemia and acute myeloid leukemia. Expert Review of Hematology 15:9, pages 833-847.
Read now
Monia Marchetti, Luca Albertin, Giulia Limberti & Manuela Canicattì. (2022) Pharmacoeconomic considerations for acute myeloid leukemia pharmacotherapy. Expert Opinion on Pharmacotherapy 23:2, pages 263-272.
Read now

Articles from other publishers (1)

Roberto Cairoli, Gianluca Furneri, Roberto Di Virgilio, Barbara Veggia & Felicetto Ferrara. (2023) Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy. BMC Health Services Research 23:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.